Defining and refining international donor support for combating the AIDS pandemic

Area of Science:

• Global Health
• Epidemiology
• Development Economics

Background:

• The international response to the Acquired Immunodeficiency Syndrome (AIDS) epidemic is disproportionately low compared to its severity.
• Historical aid levels have declined relative to the increasing prevalence of Human Immunodeficiency Virus (HIV) infection.

Purpose of the Study:

• To analyze the inadequacy of international financial aid for HIV/AIDS control in sub-Saharan Africa.
• To propose a framework for increased and more effective international assistance to combat the AIDS pandemic.

Main Methods:

• Analysis of self-reported financial data from international aid donors to the Organization for Economic Cooperation and Development (OECD) between 1996 and 1998.
• Estimation of total donor spending on HIV/AIDS control, accounting for under-reporting and misreporting.

Main Results:

• Between 1996-1998, average annual aid for AIDS control in sub-Saharan Africa was approximately $69 million, potentially reaching double this amount.
• Current aid levels equate to roughly $3 per HIV-infected person, a stark contrast to the epidemic's scale.
• Financial constraints are identified as the primary barrier to progress in AIDS control, overriding perceived lack of government interest in affected nations.

Conclusions:

• A significant increase in international assistance, at least $7.5 billion annually within three years, is essential for a meaningful response to the AIDS pandemic.
• Aid should be provided as grants, not loans, to the poorest countries and fund projects prioritized by recipient nations and validated by independent scientific experts.
• Comprehensive funding must address prevention, treatment (including antiretroviral therapy), and mother-to-child HIV transmission, a scale of aid readily affordable by OECD economies.